Company: STAA
Filing Date: 2025-12-08
Form Type: DFAN14A
Source: 0001213900-25-119309
Chunk: 11

Company: STAAR SURGICAL CO
Filing Date: 2025-12-08
Form: DFAN14A
Chunk 11
---
 see no reason for shareholders to support what is essentially the same defective transaction, at the same inadequate price, that so many shareholders vociferously opposed just a few weeks ago.

The Path Forward

In our view, the Board’s persistent procedural maneuvering to force through an obviously flawed transaction demonstrates a stunning lack of fidelity to the interests of shareholders and other stakeholders. We believe new directors are urgently needed to restore shareholder trust and properly steward the Company in its next chapter.

To that end, we are in the process of calling a special meeting to reconstitute the Board by removing the directors who, in our view, are most responsible for orchestrating, incentivizing, and perpetuating this ill-conceived proposed transaction.

We do not seek, and have never sought, control of STAAR. Instead, we seek a Board that is independent, dedicated to serving shareholder interests, and committed to working diligently to help STAAR realize its immense potential.

But before we can enhance the Board, we must first reject the proposed transaction.

The performative go-shop process, which was unquestionably tilted in Alcon’s favor, does nothing to persuade us that the original deal terms have somehow been alchemized into a value-maximizing transaction that warrants shareholder approval. To the contrary, the developments of the last several weeks have only reinforced our view that the proposed transaction remains burdened by a conflicted Board and a deficient process, poor timing, and inadequate price.

We urge shareholders to join us in voting “ AGAINST” STAAR’s proposed sale to Alcon on the GREENProxy Card so that we can finally Let STAAR Shine.

Sincerely,

Neal Bradsher

Founder and President

Broadwood Capital, Inc., General Partner of Broadwood Partners, L.P.

If you have any questions or require any assistance with voting your shares, please contact our proxy solicitor, Saratoga Proxy Consulting LLC, by calling (212) 257-1311 or toll free at (888) 368-0379, or by email at info@saratogaproxy.com. If you have already voted for the merger or given your vote to STAAR’s proxy solicitor over the phone, you may change your vote by voting a later-dated proxy AGAINST the deal. Only your latest dated vote counts.

About Broadwood

Broadwood Partners, L.P. is managed by Broadwood Capital, Inc. Broadwood Capital is a private investment firm based in New York City. Neal Bradsher is the President of Broadwood Capital.

<div align='center